Khiron Life Sciences (Khiron Life Sciences) Long-Term Capital Lease Obligation : $0.26 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Khiron Life Sciences Long-Term Capital Lease Obligation?

Khiron Life Sciences's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.26 Mil.

Khiron Life Sciences's quarterly Long-Term Capital Lease Obligation stayed the same from Mar. 2022 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) but then increased from Jun. 2022 ($0.00 Mil) to Sep. 2022 ($0.26 Mil).

Khiron Life Sciences Long-Term Capital Lease Obligation Historical Data

The historical data trend for Khiron Life Sciences's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Long-Term Capital Lease Obligation Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	0.26

Khiron Life Sciences (OTCPK:KHRWF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Khiron Life Sciences Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRWF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.